The Valley Desk

NCT01767194 · Interventional trial

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Overall registry status Completed

Phase 2

Conditions Ganglioneuroblastoma, Recurrent Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov